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Abstract
Light influences sleep and alertness either indirectly through a well-characterized circadian pathway or directly through yet
poorly understood mechanisms. Melanopsin (Opn4) is a retinal photopigment crucial for conveying nonvisual light
information to the brain. Through extensive characterization of sleep and the electrocorticogram (ECoG) in melanopsin-
deficient (Opn4
2/2) mice under various light–dark (LD) schedules, we assessed the role of melanopsin in mediating the
effects of light on sleep and ECoG activity. In control mice, a light pulse given during the habitual dark period readily
induced sleep, whereas a dark pulse given during the habitual light period induced waking with pronounced theta (7–
10 Hz) and gamma (40–70 Hz) activity, the ECoG correlates of alertness. In contrast, light failed to induce sleep in Opn4
2/2
mice, and the dark-pulse-induced increase in theta and gamma activity was delayed. A 24-h recording under a LD 1-h:1-h
schedule revealed that the failure to respond to light in Opn4
2/2 mice was restricted to the subjective dark period. Light
induced c-Fos immunoreactivity in the suprachiasmatic nuclei (SCN) and in sleep-active ventrolateral preoptic (VLPO)
neurons was importantly reduced in Opn4
2/2 mice, implicating both sleep-regulatory structures in the melanopsin-
mediated effects of light. In addition to these acute light effects, Opn4
2/2 mice slept 1 h less during the 12-h light period of
a LD 12:12 schedule owing to a lengthening of waking bouts. Despite this reduction in sleep time, ECoG delta power, a
marker of sleep need, was decreased in Opn4
2/2 mice for most of the (subjective) dark period. Delta power reached after a
6-h sleep deprivation was similarly reduced in Opn4
2/2 mice. In mice, melanopsin’s contribution to the direct effects of light
on sleep is limited to the dark or active period, suggesting that at this circadian phase, melanopsin compensates for
circadian variations in the photo sensitivity of other light-encoding pathways such as rod and cones. Our study, furthermore,
demonstrates that lack of melanopsin alters sleep homeostasis. These findings call for a reevaluation of the role of light on
mammalian physiology and behavior.
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Introduction
Light exerts strong effects on human physiology and behavior,
including entrainment of circadian rhythms [1–3], suppression of
melatonin release [4], regulation of heart rate and body
temperature [5], alertness [6], and cognition [7]. The effects of
light on behavior have been classified either as indirect, shifting the
phase of the circadian rhythm (photic entrainment), or as direct,
affecting behavior in a circadian-independent fashion, such as
occurs in light avoidance in nocturnal species (masking). Processing
of photic information has been studied extensively in the context of
circadian biology with an emphasis on the nonvisual effects of light
[8–10] mediated by melanopsin, a photopigment involved in
irradiance level detection [11–13]. In mammals, melanopsin is
exclusively expressed in retinal ganglion cells (RGCs) [14] and
retinal pigment epithelium [15]. Melanopsin plays a major role in
the photic phase shifting of circadian rhythms [16,17]. The role of
light in the circadian regulation of sleep and wakefulness and the
pathways by which melanopsin-containing RGCs influence the
circadian system, particularly the suprachiasmatic nuclei (SCN), are
well documented [18,19]. In contrast, the noncircadian, direct
effects of light on sleep and wakefulness as well as the pathways
relaying these effects remain poorly understood. Direct effects of
light are difficult to distinguish from visual and circadian influences.
Such effects are mainly known to acutely promote alertness in day-
active species and sleep in night-active species.
PLoS Biology | www.plosbiology.org 1 June 2009 | Volume 7 | Issue 6 | e1000125The purpose of this study was to take advantage of mice lacking
melanopsin (Opn4
2/2) to provide an in-depth analysis of the direct
effects of light on sleep, wakefulness, and the electrocorticogram
(ECoG) and how these effects are modulated by time of day under
various light–dark (LD) regimes. Two recent studies [20,21],
performed concomitantly to ours, confirmed that in the absence of
melanopsin a single light pulse, presented during the dark period,
failed to induce sleep. This led to the conclusion that melanopsin
mediates the direct effects of light on sleep [20,21]. By probing the
effects of light on sleep across the 24-h day, we demonstrate here
that the failure to respond to light in Opn4
2/2 mice was restricted
to the dark period, implicating other light-encoding pathways in
mediating the direct effects of light at other times of day. Another
novel aspect of our study is the finding that melanopsin plays a role
in shaping rhythmic ECoG activity. In particular, the amplitude of
the sleep-wake–dependent changes in ECoG delta power, a
marker of sleep need, was reduced in Opn4
2/2 mice compared to
that of wild-type littermate controls. Finally, to gain insight into
the pathways relaying these direct effects, we used c-Fos
immunohistochemistry in SCN neurons and in galaninergic
‘‘sleep-active neurons’’ of the ventrolateral preoptic (VLPO) area:
key circadian and sleep-promoting structures in the hypothalamus,
respectively. The VLPO receives direct projections from mela-
nopsin-containing RGCs [22–24] and thus represents a candidate
brain area to mediate the direct effects of light on sleep.
Results
We compared the direct effects of light between mice carrying a
targeted disruption of the melanopsin gene (Opn4
2/2; see [17] and
Text S1 for details) and their wild-type, littermate controls (Opn4
+/+).
We used various lighting schedules to evaluate the effect of light on
sleep and the ECoG (for an overview, see Figure S1). Among these
schedules were the standard baseline LD 12-h:12-h (12:12) schedule
the mice were kept under, a single 1-h light and a single 1-h dark
pulse given during the habitual 12-h dark and light periods,
respectively, and 24 h under a LD 1-h:1-h (1:1) cycle.
Melanopsin Modulates the Direct Effects of Light on
Sleep and the ECoG
In a first set of experiments, the acute effects of light and
darkness on sleep and the ECoG were investigated by exposing
mice of both genotypes to a single, 1-h pulse of light administered
3 h after the habitual LD transitions; i.e., Zeitgeber time (ZT)15–
16 (with ZT0 referring to the time of light onset) and to a 1-h dark
pulse given 3 h after light onset (i.e., ZT3–4). Mice were otherwise
kept under LD 12:12 conditions, and at least 14 d separated any
two recording conditions.
In Opn4
+/+ mice, the light pulse readily increased the amounts
of both rapid eye movement (REM) and non-REM (NREM) sleep
at the cost of wakefulness, whereas the same light pulse in Opn4
2/2
mice failed to affect time spent in either behavioral state for the
duration of the light pulse (Figure 1A). This lack of a response
demonstrates that, at least at this time of day (see LD 1:1 results
below), melanopsin contributes significantly to the acute effect of
light on sleep.
Light-to-dark transitions induce waking and alertness in
nocturnal rodents. Accordingly, in Opn4
+/+ mice, a 1-h dark pulse
induced an immediate increase in time spent awake (Figure 1B),
and the ECoG during wakefulness showed a rapid and prolonged
induction in ECoG theta (7–10 Hz) and gamma (40–70 Hz)
activity (Figure 1C and 1D), the ECoG correlates of exploratory
behavior and alertness in rodents [25,26]. The dark pulse also
induced waking in Opn4
2/2 mice. Although their immediate
response was somewhat delayed (compare genotypes for the
increase in waking in the 5 min before and after dark onset in
Figure 1B), the hourly amount of waking (and sleep) did not differ
between genotypes (unpublished data). The changes in ECoG
theta and gamma activity that follow the transition into darkness
seemed, however, to be modulated by melanopsin because they
were delayed by ca. 25 min (Figure 1C and 1D). Upon restoring
the normal light condition 1 h later, Opn4
2/2 mice stayed awake
longer, consistent with the light-pulse results (Figure 1B and 1A).
The Effects of Light and Dark Pulses on Sleep and Waking
Vary with Time of Day
The single pulses of light and darkness probed their effects on
sleep and waking at specific times of day only. To obtain a more
complete account of the genotype differences of these interven-
tions, we maintained mice under a short, 1-h LD cycle (LD 1:1) for
a 24-h period. This lighting schedule was used first in the rat to
investigate the direct effects of light on sleep across the circadian
cycle [27]. Also under these conditions, 1-h periods of light
induced sleep, and 1-h periods of darkness favored wakefulness.
Irrespective of the effect of this ultradian LD cycle on sleep and
wakefulness, a circadian modulation of the average levels of sleep
and waking reached within the subjective 12-h light period and
subjective 12-h dark period is preserved in wild-type mice
(Figure 2A; Table 1). The protocol has the potential drawbacks
that light given at any one hour might influence its effects during
subsequent hours and that animals could entrain their ultradian
sleep–wake organization to this schedule. We did not see evidence
of the former effect as the relative effect of the LD alteration on
Author Summary
Light affects sleep in two ways: indirectly through the
phase adjustment of circadian rhythms and directly
through nonvisual mechanisms that are independent of
the circadian system. The direct effects of light include the
promotion of sleep in night-active animals and of alertness
in diurnal species. We analyzed sleep and the electroen-
cephalogram (EEG) under various light–dark regimens in
mice lacking melanopsin (Opn4
2/2), a retinal photopig-
ment crucial for conveying light-level information to the
brain, to determine the role of melanopsin, as opposed to
rod and cones, in mediating these direct effects of light.
We show that melanopsin mediates the direct effects of
light during the subjective dark period, whereas rods and
cones contribute to these effects in the light period. Our
finding that ‘‘sleep-active’’ (i.e., galanin-positive) neurons
of the anterior hypothalamus are not activated by light in
Opn4
2/2 mice suggests that these neurons are part of the
circuitry whereby light promotes sleep. Also, the alerting
effects of transitions into darkness were less pronounced in
Opn4
2/2 mice judged on the reduced increase in EEG theta
and gamma activity. Finally, and unexpectedly, the rate at
which the need for sleep, quantified as EEG delta power,
accumulated during wakefulness was found to be reduced
inOpn4
2/2 miceboth duringbaselineand sleepdeprivation
conditions, implicating a photopigment in the homeostatic
regulation of sleep. We conclude that melanopsin contrib-
utes to the direct effects of light and darkness, and in
interaction with circadian and homeostatic drive, deter-
mines the occurrence and quality of both sleep and waking.
If confirmed in humans, our observations will have
applications for the clinical use of light as well as for societal
lighting conditions.
Melanopsin as a Sleep Modulator
PLoS Biology | www.plosbiology.org 2 June 2009 | Volume 7 | Issue 6 | e1000125Figure 1. Direct effects of a 1-h light (L) and a 1-h dark (D) pulse on the sleep–wake distribution (A and B) and the waking ECoG
(during the 1-h D pulse; panels [C and D]) under an LD 12:12 schedule. (A) The L pulse, administered during the habitual dark period (ZT 15–
16), induced NREM (N) and REM (R) sleep at the expense of wakefulness (W) in Opn4
+/+ mice (p,0.05; post hoc paired t-tests). No response was
observed in Opn4
2/2 mice. Values during the 1-h L pulse were compared to baseline values obtained in a 3-h window centered around the time of
the pulse (ZT 14–17). (B) Time course of time spent awake across the 1-h D pulse, administered during the habitual light period (ZT3–4). Waking
values (waking minutes/5-min intervals) over 3 h (1-h light before and 1-h light after D pulse) and centered on the D pulse (ZT3–4; grey area). Note
the delayed response in Opn4
2/2 mice after the D pulse when light is applied again. Melanopsin-deficient mice stay awake and return to sleep only
after 35 min. Red asterisks (*) denote 5-min intervals with significant genotype effects (p,0.05; post hoc t-tests). (C) Heat map of the time course of
spectral changes in the waking ECoG during the 1-h D pulse. ECoG power density was expressed as percentage of individual waking ECoG spectra
obtained during the baseline light period (=100%). Warmer colors denote relative increases, colder colors, decreases versus baseline ECoG activity.
Relative spectral profiles were calculated over 10 min of waking at 5-min increments (i.e., 13 spectra/hour). (D) as in (C) but summarized for the theta
(7–10 Hz) and gamma (40–70 Hz) frequency bands. Note the smaller and delayed activation in Opn4
2/2 mice. Asterisks indicate significant genotype
differences (p,0.05; post hoc t-tests); red-filled circles indicate significant differences from baseline (p,0.05; post hoc paired t-tests). Values represent
means6SEM (n=6 and 7, for Opn4
+/+ and Opn4
2/2, respectively).
doi:10.1371/journal.pbio.1000125.g001
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(Figure 2A–2C), but after the initial three cycles (i.e., after ZT6),
wild-type mice seemed capable of anticipating dark onset, because
increases in wakefulness started preceding it (Figures 2B and S2).
Visual inspection of the hourly values of wakefulness reached
under the LD 1:1 protocol suggests that Opn4
2/2 mice have a
reduced response to light in the (subjective) dark period
(Figure 2A); i.e., the time at which we and others [20,21]
administered the single 1-h light pulse (see above). This reduction
was, however, not observed at other times of day, and the LD-
induced changes in time spent awake did not differ from wild-type
mice during the subjective light period (Figure 2A–2C). The
capacity of the 1-h LD cycles to alter the sleep–wake distribution
was further analyzed by aligning the subsequent 1:1-h LD cycles
(Figures 2B and S2). This time course analysis revealed that, as was
observed after the single dark-pulse experiment (Figure 1B),
Opn4
2/2 mice were again slower in initiating sleep after light onset
(Figure 2B). Analyses of variance confirmed that the time course of
the LD-induced changes in wakefulness and NREM sleep varied
significantly according to genotype and time of day (i.e., 12-h
subjective light period versus 12-h subjective dark period;
Figure 2B). Changes in the time course observed in Figure 2B
were summarized by estimating the amplitude of sine waves of best
fit for individual mice (Figure 2C; see Text S1 for details). This
analysis also confirmed that genotype affected the light-induced
changes in wakefulness only during the subjective dark period
(Figure 2C). Especially between ZT15–21, the increase of
wakefulness during the 1-h dark intervals compared to the 1-h
mean value in the preceding light intervals was no longer
significant in Opn4
2/2 mice (+4.264.1 min; p=0.38 and
+26.265.3 min; p=0.038; for Opn4
2/2 and Opn4
+/+ mice,
respectively; paired t-tests), and this increase differed between
genotypes (one-way ANOVA; p=0.020). It thus seems that only
during this time melanopsin contributed significantly to the direct
effects of light on wake and sleep duration.
Light-Induced c-Fos Expression in SCN Neurons and
Galaninergic Neurons of the VLPO
As expected from our previous work and that of others [16,17],
a 1-h light pulse administered during the dark period induced c-
Fos immunoreactivity in the SCN in both genotypes (two-way-
ANOVA, light-pulse effect: p,0.001, followed by post hoc Fisher
protected least significant difference [PLSD]: p,0,05); however,
the induction was half that observed in Opn4
+/+ mice (two-way
ANOVA, light6genotype interaction: p,0,001; light-pulse effect:
Figure 2. Direct effects of 1-h light (L) and 1-h dark (D) pulses on the sleep–wake distribution under a LD 1:1 schedule. (A) Hourly
mean values of wakefulness during the LD 1:1 cycle. Hourly L pulses suppressed wakefulness, but this effect seemed to vary with time of day in
Opn4
2/2 mice and was especially small between ZT15 and ZT21. Grey horizontal bars mark the subjective dark period (i.e., the 12-h dark period of the
preceding days under LD 12:12). (B) Average time course of the LD-induced changes in wakefulness (W; upper), NREM sleep (N; middle), and REM
sleep (R; lower panels) during the 12-h subjective light (left) and subjective dark (right) period. Values represent means (6SEM) over 5-min intervals in
the hour preceding, during, and following the six 1-h dark pulses in the subjective light and dark periods, respectively. A three-way ANOVA with
factors ‘‘genotype,’’ ‘‘time of day’’ (subjective light versus subjective dark period), and ‘‘time course’’ (5-min values) revealed that for W and N, time
course was significantly affected by time of day and genotype (interactions: genotype6time of day: W and N: p,0.0001; R: p=0.017; genotype6time
course: W and N: p,0.0001; R: p=0.14; time of day6time course: W: p=0.019; N: p=0.048; R: p=0.18). Red filled circles denote 5-min intervals with
significant genotype effects (p,0.05; post hoc t-tests). Black (Opn4
2/2) and grey (Opn4
+/+) sine waves represent best fits to the data points. (C)
Changes in the time course observed in (B) were summarized and quantified by determining the amplitude of sine waves of best fit for each
individual mouse (see Text S1 for details). The thus estimated amplitude of the LD-induced changes in wakefulness was affected by time of day (two-
way ANOVA interaction genotype6time of day p=0.033) and was significantly smaller in Opn4
2/2 mice during the subjective dark period compared
to the subjective light period and compared to the values obtained in wild-type mice in both conditions (red asterisk; post hoc t-tests; p,0.05).
doi:10.1371/journal.pbio.1000125.g002
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+/+ vs. Opn4
2/2, post hoc Fisher PLSD, p,0,05) (Figure 3).
This reduction in c-Fos immunoreactivity has been functionally
linked to the reduced ability to phase shift circadian rhythms in
these mice. This does not, however, rule out the possibility that the
reduced activation of SCN neurons could also contribute to the
reduced direct effects of light on sleep and waking described here.
We further determined whether melanopsin conveys light
information to the VLPO, in particular to the galaninergic
sleep-active neurons, using double staining for c-FOS protein
(immunohistochemistry) and for galanin mRNA (in situ hybrid-
ization). Whereas overall c-Fos immunoreactivity in the VLPO
area was not significantly affected by the light pulse, in Opn4
+/+
mice, the percentage of galanin-containing (GAL) neurons
coexpressing c-Fos did significantly increase compared to the
control condition (i.e., darkness) (Figure 4). In contrast, in Opn4
2/2
mice, GAL c-Fos-costained neurons were present at low levels in
both lighting schedules (2%), and no induction of c-Fos in GAL
neurons was observed, suggesting that at least at this time of day,
melanopsin-containing RGCs contribute significantly to the effects
of light on the activity of these sleep-active VLPO neurons (two-way
ANOVA, light-pulse effect: p,0.05, light6genotype interaction:
p,0,05; light-pulseeffect: Opn4
+/+: p,0,05; Opn4
2/2: p=0,23, post
hoc Fisher PLSD).
Sleep and Quantitative ECoG Analyses under Standard
Light–Dark Conditions
The mouse is a nocturnal species that avoids light of higher
intensity. Opn4
2/2 mice are no exception and, similar to their
littermate wild-type controls (Opn4
+/+), mostly sleep during the
light period and are awake during the dark period of the LD 12:12
cycle (Figure 5A; Table 1). Nevertheless, Opn4
2/2 mice lose ca.
1 h of NREM sleep per day relative to Opn4
+/+ mice. This marked
loss of sleep occurred during the 12-h light period exclusively
(Figure 5B) and resulted in an attenuation of the diurnal
distribution of sleep and waking (Table 1). This genotype
difference could be due to a reduced capacity of light to induce
sleep or to suppress wakefulness, an interpretation underscored by
the results of the light- and dark-pulse experiments (Figure 1A and
1B) and the LD 1:1 experiment (Figure 2A). Indeed, for both
genotypes, the levels of sleep reached during the 1-h light intervals
during the subjective light period of the LD 1:1 schedule were
similar to those reached during the light period of the LD 12:12
schedule; i.e., Opn4
2/2 mice slept less when light was present
during the (subjective) light period of both the LD 1:1 and LD
12:12 (Table 1). Moreover, the sleep loss observed in Opn4
2/2
mice was associated with an overall deficit in ECoG delta power
during NREM sleep (see below).
The wakefulness present during the light period is organized in
more or less regularly occurring bouts lasting on average about 20–
25 min [28] (Figure S1; Table S1). To examine in more detail the
mechanism underlying the differences in sleep time during the light
period, we analyzed these spontaneous waking bouts. In Opn4
+/+
mice, after 20 min of sustained wakefulness, waking values reverted
quicklytothelowvaluescharacteristicofthelightperiod(Figure5C).
In contrast, in Opn4
2/2 mice, these waking bouts lasted on average
11 min longer (Table S1), and values remained above wild-type
levels for 30 min (Figure 5C). The similarity between these results
and the results observed after the single dark pulse (Figure 1B)
Table 1. Time spent asleep and awake under the LD 12:12 and LD 1:1 schedules.
Schedule Time spent Opn4 Genotype Waking (h) NREMS (h) REMS (min)
LD12:12 12-h light period
2/2 4.8060.21
a 5.9260.18
a 77.162.6
+/+ 3.7460.17 6.9560.17 77.8611.1
12-h dark period
2/2 6.5960.20
b 4.5660.18
b 50.862.3
b
+/+ 6.7960.37
b 4.5160.33
b 41.966.5
b
LD difference
2/2 1.8060.17
a 1.3660.14
a 26.363.2
+/+ 3.0460.34 2.4460.29 35.966.6
24 h
2/2 11.3960.37 10.4860.33 127.963.6
+/+ 10.5360.47 11.4760.44 119.7616.9
LD1:1 Subjective 12-h light period
2/2 6.9660.34
a 4.1960.29
a 50.863.8
a
+/+ 5.1560.48 5.6660.40 71.365.1
Subjective 12-h dark period
2/2 6.4460.26 4.7160.21 51.264.7
+/+ 6.4860.18
b 4.6960.16 49.961.7
b
24 h
2/2 13.4060.36
a 8.960.34 101.963.4
a
+/+ 11.6360.65 10.3560.56 121.266.7
12 1-h light periods
2/2 5.5160.29
a 5.4760.23
a 61.365.2
a
+/+ 3.5360.36 7.1360.29 80.564.2
12 1-h dark periods
2/2 7.8960.25
b 3.4460.23
b 40.663.6
b
+/+ 8.1060.87
b 3.2260.76
b 40.767.1
b
Under both schedules, Opn4
2/2 mice displayed significantly less NREM sleep (NREMS; and were awake more) than Opn4
+/+ mice during the (subjective) 12-h light (L)
periods. This resulted in a significantly decreased amplitude of the circadian distribution (LD difference) of NREMS time (and waking) in Opn4
2/2 mice. Under the LD 1:1
schedule, Opn4
2/2 mice slept less compared to Opn4
+/+ mice during all 12 1-h L pulses of the entire 24-h d. Also under the LD1:1 schedule, the circadian distribution of
sleep and waking observed under the LD 12:12 condition is maintained only in Opn4
+/+ mice (subjective 12-h L period, ZT0–12, compared to the. subjective 12-h dark
(D) period, ZT12–24).
aIndicates significant genotype differences.
bThe difference between (subjective) 12-h D and L periods for each lighting schedule and genotype (p,0.05; post hoc t-test). Values represent means6SEM (LD 12:12
n=9/genotype; LD 1:1 n=3and4,forOpn4
+/+ and Opn4
2/2, respectively).
doi:10.1371/journal.pbio.1000125.t001
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to induce sleep in Opn4
2/2 mice also contributed to an overall
reduction in sleep time during the light period.
Quantitative analysis of the ECoG during the three behavioral
states revealed an increase in ECoG power density in the theta and
gamma frequency bands in Opn4
2/2 mice compared to in Opn4
+/+
mice (Figure 6). These differences were present both during the
light and dark periods of LD 12:12 (unpublished data). Such
ECoG changes during NREM sleep are typically associated with
reduced sleep quality [29], whereas during wakefulness, ECoG
activity in these bands is associated with exploratory behavior,
alertness, and cognition [25,26,30], and is thus markedly increased
during waking compared to NREM sleep [31]. Genotype effects
on theta activity could be analyzed in more detail in REM sleep
because theta oscillations are especially prevalent and regular
during this state [32]. Theta peak power during both REM sleep
and wakefulness was nearly doubled in Opn4
2/2 mice compared
to controls (Figure 6; Table S2). The frequency of the theta
oscillation during REM sleep was faster in Opn4
2/2 mice
compared to Opn4
+/+ mice during the light period, but not during
the dark period. In mice, theta frequency during REM sleep is
usually slower in the light compared to the dark period [32] (Table
S2). In Opn4
2/2 mice, no evidence for such dark–light slowing
was, however, found (Table S2), suggesting that the melanopsin
pathway can directly or indirectly modulate hippocampal activity.
Altered Homeostatic Regulation of Sleep in Opn4
2/2
Mice
Curtailing sleep time usually results in an increased need for
sleep. It is therefore surprising that in Opn4
2/2 mice, levels of
ECoG delta power during NREM sleep, a reliable correlate of
sleep need, were generally lower while less time was spent in
NREM sleep compared to Opn4
+/+ mice. This reduction in delta
power was especially pronounced in the dark periods of the LD
12:12 schedule (Figure 7A). The same difference was observed
during the subjective dark period under the LD 1:1 schedule
(Figure 7B) and thus did not depend on the presence or absence of
light. Moreover, this reduction was not associated with an
increased fragmentation of sleep (Figure S3) that could have
interfered with the expression of delta oscillations.
The unexpected reduction of delta oscillations observed in
melanopsin-deficient mice might result from alterations in the
properties of the sleep homeostat. We tested the possibility that the
build-up of a pressure for sleep when animals are awake occurs at
a slower rate in a sleep deprivation experiment. Mice of both
genotypes were kept awake by gentle handling for 6 h starting at
light onset (ZT0–6). The level of delta power reached during
NREM sleep immediately following the sleep deprivation was
significantly lower in Opn4
2/2 mice as compared to wild-type
animals (Figure 7C), suggesting that in the absence of melanopsin,
the dynamics of the sleep homeostat are altered.
Figure 3. Effects of a 1-h light (L) pulse on c-Fos immunoreactivity in the SCN. (A–D) Effects of the L pulse administered during the habitual
dark period (ZT15–16) on c-Fos immunoreactivity in the SCN of Opn4
+/+ and Opn4
2/2 mice. Few c-Fos immunoreactive cells (labeled red) are found in
the dorsomedial (arginine-vasopressin [AVP]-containing) SCN (labeled green) in control (no L pulse) animals (A and B). Light induced c-Fos in the
retino-recipient zone of the SCN in Opn4
+/+ (C) and to a lesser extend in Opn4
2/2 mice (D). oc; optic chiasm. Scale bars in (A–D) indicate 75 mm. (E)
Number of c-Fos immunoreactive neurons in the SCN. The L pulse induced c-Fos in the retino-recipient part of the SCN in both genotypes (two-way
ANOVA, light pulse effect: p,0,001; an asterisk (*) indicates post hoc Fisher PLSD: p,0.05), but this light induced c-Fos immunoreactivity is
significantly reduced in Opn4
2/2 mice (two-way ANOVA, the star indicates light pulse6genotype interaction: p,0,001).
doi:10.1371/journal.pbio.1000125.g003
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PLoS Biology | www.plosbiology.org 6 June 2009 | Volume 7 | Issue 6 | e1000125Figure 4. Effects of a 1-h light (L) pulse on c-Fos immunoreactivity in the VLPO. (A) ‘‘Sleep-active neurons’’ of the VLPO identified by ISH
contain galanin mRNA (labeled green). (B) Top: histograms represent the number of VLPO neurons expressing galanin mRNA or c-FOS protein per
section (mean6SEM). Bottom: VLPO costained (galanin+c-Fos) neurons expressed as a percentage of the total number of galanin mRNA-positive
neurons (mean6SEM). A two-way ANOVA (with factors light pulse and genotype) revealed that the L pulse induced an increase in VLPO costained
cells in Opn4
+/+, but not in Opn4
2/2 mice (Two-way ANOVA, L-pulse effect: p,0,05; L pulse6genotype interaction: a star indicates p,0.05; the
asterisk [*] indicates post hoc Fisher PLSD: p,0.05). The light-induced immunoreactivity in VLPO in wild-type animals is specific to galaninergic
neurons and of a large magnitude; however, the proportion of c-Fos-stained galanin neurons is low (e.g., Opn4
+/+: +L pulse: 9% of total number of
galanin mRNA-containing cells). (C) In the absence of a L pulse (control condition at ZT16), c-Fos immunoreactivity was found in nongalanin mRNA-
containing neurons in the VLPO of Opn4
+/+. (D) The L-pulse-induced c-Fos expression (labeled red) in some of the galanin mRNA-positive (green)
neurons of the VLPO in Opn4
+/+ (indicated by arrows). (E and F) In Opn4
2/2 mice, the same low number of galanin mRNA-positive neurons express c-
Fos in both conditions, without (E) or with (F) light pulse. 3v, third ventricle; LP, L pulse administered during the habitual dark period (ZT15–16); MPO,
medial preoptic area; oc, optic chiasm. Scale bars in (A) and (C–F) indicate 100 mm.
doi:10.1371/journal.pbio.1000125.g004
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Melanopsin-containing RGCs modulate a broad range of
physiological responses to light, ranging from pupil constriction to
circadian phase shifting. Here, we demonstrate that melanopsin-
containing RGCs can also contribute to the acute light induction of
sleep. Previously, it was assumed that only the rod–cone system was
involved in these direct effects of light through conscious alerting. In
humans, a role for melanopsin in the direct effects of light has already
been suggested [33,34] because the sensitivity of sleep–wake to acute
light exposure is at a maximum at short wavelengths (460–480 nm),
corresponding to melanopsin’s peak light sensitivity at 480 nm. The
application of blue light in normal subjects has been reported to
activate multiple brain areas within seconds [35], and the observed
responses to 1-h light or dark pulses quantified here in mice occur
quickly as well (within minutes).
Circadian Gating of the Direct Effects of Light
A main finding of our study is the result of the LD 1:1
experiment that revealed that time of day modulated the acute
effects of light and dark only in Opn4
2/2 mice. During a 7-h
period of the subjective dark period, Opn4
2/2 mice did not
respond to the ongoing LD alterations with respect to sleep–wake
induction. During this time, we and others [20,21] applied the
single 1-h light pulse that has led to the conclusion that melanopsin
mediates the direct effects of light. Our data show that at other
times of day, melanopsin is not necessary for mediating these acute
light effects on sleep duration.
Because light perception in Opn4
2/2 mice depends solely on
rod–cone photoreception, it can be argued that the inability to
respond to light at specific times of day results from circadian
changes in rod–cone sensitivity. In intact mice, no time-of-day
effect was observed in the response to the LD 1:1 schedule,
suggesting that melanopsin compensates for circadian changes in
rod–cone sensitivity. Such interaction between the two photosen-
sitive systems could take place in melanopsin-containing RCGs
since these cells integrate rod–cone input important for mediating
nonvisual light information to the brain [10]. Circadian modula-
tion of retinal output has been described, and for example,
variations in rod–cone electrical coupling were shown to lead to
higher rod–cone photosensitivity during the dark period [36]. In
contrast, another study showed higher cone sensitivity during the
Figure 5. Time course of NREM sleep time and wake distribution under a standard LD 12:12 schedule. (A) Despite a similar time course,
NREM sleep levels attained during the 12-h light period were generally lower in Opn4
2/2 mice. (B) Dynamics of the accumulated differences
demonstrate that Opn4
2/2 mice lose 1 h of NREM sleep per day, a loss incurred during the light period exclusively (average of the two baseline days;
see also Table 1). (C) Sustained waking bouts in Opn4
2/2 are longer than in wild-type animals. See Table S1 for details on the definition of a sustained
bout. Red-filled circles denote significant genotype differences (p,0.05; post hoc t-tests). Values represent mean6SEM (both days n=9/genotype; for
some mice the first or second day could not be included; Opn4
+/+: day 1 n=7, day 2 n=5;Opn4
2/2 day 1 n=9, day 2 n=6).
doi:10.1371/journal.pbio.1000125.g005
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presence of melanopsin [37]. It is unknown whether such effects
exist also for the nonvisual, acute effects of light on sleep.
Melanopsin protein levels are also known to vary across the day
due to both circadian- and light-dependent influences reaching
their highest levels during the light period and lowest during the
dark period [38]. Assuming that differences in protein levels
translate into differences in (blue) light sensitivity further
complicates the issue and calls for further investigation.
We want to emphasize here that the above-described effects
concern the acute effects of light observed at the transitions
between lighting conditions. We presented evidence that mela-
nopsin also affects several aspects of sleep during the sustained 12-
h light period of the LD 12:12 schedule, including the spectral
composition of the ECoG, the frequency of theta oscillations
during REM sleep, and waking bout duration. The genotype
differences in the ECoG activation during the 1-h dark pulse was
also observed during this period of the day.
Neuronal Pathways Relaying the Direct Effects of Light
on Sleep
Although circadian gating already occurs at the level of the
retina [36,39,40], the 50% reduction in the activation of SCN
neuronal activity after a light pulse in Opn4
2/2 mice may also be
relevant for the circadian variation of the direct effects of light in
these mice. As SCN functionality is conserved in the absence of
melanopsin [9], a potential role of the SCN in also mediating the
acute, noncircadian effects of light could explain the time-of-day-
Figure 6. Average ECoG spectral profiles for each behavioral state recorded during 2 d under standard LD 12:12 conditions. Power
density in the theta and gamma frequency ranges was generally higher and in the delta frequencies lower (during NREM sleep) in Opn4
2/2 mice. Insets:
relative spectral changes quantified as log2 of the ratio between Opn4
2/2 (KO) and Opn4
+/+ (WT) power density values (e.g., 1 signifies a two-fold increase).
Line segments in red denote significant genotype differences (p,0.05; post hoc t-tests; n=9/genotype). N, NREM sleep; R, REM sleep; W, wakfulness.
doi:10.1371/journal.pbio.1000125.g006
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relay such activation since it influences key areas for sleep–wake
control, such as the VLPO.
Besides the SCN, other anatomical targets of melanopsin-
containing RGCs have been identified [22,24,41]. Among the
various projection areas, the VLPO is a good candidate for
relaying light information to sleep–wake neuronal networks. The
VLPO has been implicated in the induction of NREM sleep [42],
and galanin- and GABA-releasing neurons within the VLPO have
been functionally characterized as a cluster of sleep-active
neurons. These sleep-active neurons are thought to actively
promote sleep by inhibiting the ascending arousal systems
[43,44]. A regional analysis of c-Fos expression within the VLPO
area was conducted by Lupi et al., 2008, by real time PCR from
punched tissues [21]. This analysis revealed a 2-fold increase in c-
Fos following a 1-h light pulse in wild-type mice that was absent in
Opn4
2/2 mice. Using a different method (i.e., counting the
number of c-FOS immunoreactive cells in the VLPO), we found
little evidence for a light-induced general activation of the VLPO
area. Only the costaining of galanin and c-Fos used in our study
allows for an evaluation of transcriptional changes specific to those
VLPO neurons that could mediate the sleep-promoting effects of
light. Here, we provide the first evidence that light indeed activates
galanin-containing cells in the VLPO. This light-induced c-Fos
immunoreactivity was absent in Opn4
2/2 mice. This anatomical
result is consistent with the complete absence of sleep–wake
changes during the 1-h light pulse at this time of day, suggesting
that the VLPO might play a role in mediating these effects of light
on sleep. Our findings thus suggest that light directly impinges on
VLPO sleep-active neurons thereby shifting the balance of the
reciprocal inhibitory interaction towards sleep promotion and
arousal inhibition.
Figure 7. Time course of ECoG delta power (1–4 Hz) during NREM sleep under a standard LD 12:12 cycle, a LD 1:1 cycle, and during
recovery sleep after sleep deprivation. (A and B) Time course analyses of ECoG delta power revealed that both under LD 12:12 (A) and LD 1:1 (B)
schedules values were generally lower in Opn4
2/2 mice during the (subjective) dark periods. (C) Level of delta power reached after 6 h of sleep
deprivation (starting at light onset; ZT0–6) was lower in Opn4
2/2 mice. Mean values (6SEM) were expressed as percentage of level reached during
ZT8–12 of a preceding baseline day. Red filled circles and asterisk denote significant genotype differences (p,0.05; post hoc t-tests; (A) n=9/
genotype; (B) n=4/3 for Opn4
2/2 and Opn4
+/+ mice, respectively; (C) n=4/genotype).
doi:10.1371/journal.pbio.1000125.g007
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Correlates of Alertness and Cognition
The rapid induction of ECoG activity in both the theta and
gamma frequency bands during the dark pulse in Opn
+/+ mice is
consistent with the alerting effects of light-to-dark transitions in
a nocturnal species. Theta oscillations accompany exploratory
behavior [45] and are also involved in long-term potentiation
(LTP) and learning [46–48]. Gamma activity accompanies a
wide variety of cognitive processes, including perceptual
processing, attention, arousal, object recognition, and in
humans, language perception [49]. As in the present study,
gamma activity is often associated with the presence of theta
oscillation in rodents [50]. The downstream events initiated by
melanopsin have been suggested to affect LTP as well as
performance in learning and memory tasks [51]. In humans,
nonvisual responses related to alertness and cognition are
associated with changes in regional brain activity detected by
positron emission tomography (PET) or functional magnetic
resonance imaging (fMRI) [52,53]. Application of blue light
during a working memory task induces specific brain activity
changes within a time frame of seconds [7].
A Role for Melanopsin in Sleep Homeostasis?
ECoG delta power is widely used to reflect a sleep homeostatic
process because its level monotonically increases with wake
duration and decreases during NREM sleep [54]. The reduction
of ECoG delta power in Opn4
2/2 mice was pronounced and
present during both the LD 12:12 and LD 1:1 schedules. This
reduction was all the more surprising because NREM sleep time
was reduced in these mice, and reduced sleep time is usually
associated with increased delta power. The unexpected reduction
of delta oscillations in melanopsin-deficient mice might result from
alterations in the properties of the sleep homeostat. One possibility
is that NREM sleep may have been more efficient in reducing
sleep need in Opn4
2/2 mice. However, by comparing the ECoG
spectral profiles during NREMS, evidence to the contrary was
found; the increase in theta and gamma activity combined with
reduction of delta activity in Opn4
2/2 mice indicate that NREM
sleep seems less profound and, if anything, likely to be less efficient
in reducing sleep need and ECoG delta power [55]. The other
possibility is that the buildup of a pressure for sleep when animals
are awake occurs at a slower rate. We confirmed this possibility in
a sleep-deprivation experiment; the level of delta power reached
during NREM sleep immediately following the sleep deprivation
was significantly lower in Opn4
2/2 mice as compared to wild-type
animals. In fact, delta power levels reached after sleep deprivation
in Opn4
2/2 mice were as low as the lowest levels observed in a
panel of six inbred strains of mice [56]. This reduced
compensatory response to sleep loss suggests that indeed the need
for sleep increases at a slower rate in Opn4
2/2 mice. The
experiment also demonstrates that the reduced delta power is not
specific to lighting condition or time of day.
Although a role for melanopsin in sleep homeostasis is
unexpected and not easily reconciled with current hypotheses on
sleep homeostasis, the modulation of VLPO sleep-active neurons
by melanopsin-containing RGCs could hint to a possible
mechanism. Sleep-active neurons in the VLPO are thought to
be a neuronal substrate of sleep homeostasis because more than
50% of galanin-containing neurons express c-Fos during recovery
sleep after a sleep deprivation [57]. A final consideration that
applies to all studies using noninducible loss-of-function mutants is
that the altered relationship between the sleep–wake distribution
and ECoG delta power reflects a developmental effect.
Conclusions
Our results provide evidence that melanopsin-containing RGCs
contribute to the noncircadian, nonvisual direct effects of light on
sleep and the ECoG correlates of alertness and cognition.
Melanopsin’s contribution to the acute affects of light on sleep
duration was however limited to a ca. 7-h time window. Our
findings suggest that the acute photic sleep promotion stems, at
least partly, from a stimulation of VLPO sleep-active neurons,
which in return, would lead to an inhibition of the arousal systems.
Apart from these direct effects of light observed at the transitions
between lighting conditions, the daily loss of NREM sleep over the
12-h light period in Opn4
2/2 mice provides evidence that
melanopsin also modulates the expression of sleep under sustained
periods of light exposure. If confirmed in humans, our observa-
tions concerning the time-dependent effects of melanopsin’s
contribution to the acute effects of (blue) light as well as the
effects of sustained light exposure will have applications for the
clinical use of light therapy as well as for 24-h patterns in
luminance [58]. Finally, the discovery that the homeostatic
regulation of sleep need can be affected by a photopigment is
intriguing and represents a novel concept in the field of sleep
regulation.
Materials and Methods
Animals
All experiments were performed on adult male Opn4
2/2 mice
and wild-type littermates (as controls), and carried out in
accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals as well as local veterinary
office and use committees at Stanford University (for details and
genotyping, see Text S1 and Ruby et al. (2002) [17]).
ECoG Recordings and Analyses
The methods concerning the recording and analysis of the
ECoG in mice are described in detail in Text S1 and elsewhere
[32,59]. Briefly, ECoG and electromyogram (EMG) recordings
from mice implanted with a classical set of electrodes, were
collected (using commercial hardware, EMBLA, and software,
Somnologica-3) for the following conditions: (1) two continuous
baseline days under LD 12:12 cycle; (2) a 1-h light pulse (white
fluorescent tubes, Philips F32T8/TL741 Hi-Vision 40 W,
4,100 K [Philips Lighting], broad spectrum, mainly 400–
800 nm) administered 3 h after dark onset (ZT 15), (3) 1-h dark
pulse administered 3 h after light onset (ZT 3), (4) a 1:1 LD cycle
for 24 h, and (5) 6-h sleep deprivation starting at light onset. The
behavior in each 4-s epoch was classified as waking, REM sleep, or
NREM sleep based on the ECoG and EMG signals according to
standard criteria [32]. The ECoG signal (analog-to-digital
converted) was subjected to discrete Fourier transform (DFT)
yielding power spectra at 0.25-Hz resolution. For each state, an
ECoG spectral profile (0 to 90 Hz) was constructed by averaging
all 4-s epochs scored as that state.
In Situ Hybridization (ISH) and Immunohistochemistry
(IHC)
Galanin ISH and c-Fos immunostaining on frozen sections with
or without (control condition) a prior 1-h light exposure was
carried out as described previously [60,61] and are detailed in
Text S1. Staining of GAL mRNA was chosen instead of staining
the protein because it has been shown in mice that cell body
staining of galanin-containing neurons by IHC is only reliable in
colchicine-treated animals. In Opn4
+/+ and Opn4
2/2 mice (n=6of
each genotype), identification of c-Fos immunoreactive cells and
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as well as without a light pulse as a negative control. Sleep was
recorded in these animals, several weeks before, under a light pulse
identical to the light pulse administered the day of the perfusion to
confirm that their response to light was similar to those of the
whole group. Before ISH series of 18-mm-thick sections were
pretreated by an antigen retrieval procedure [62]. The mouse
galanin probe (National Center for Biotechnology Information
[NCBI] BC044055, covering a 716-base sequence of the GAL
prepro-mRNA) was used in a dilution of 1:500. The ISH protocol
preceding the immunohistochemical protocol was identical to the
procedure described previously [60,61]. GAL mRNA was
visualized using a horse radish peroxidase (POD)-labeled sheep-
anti-digoxiginin antibody (Roche 1207733, diluted 1:200), and
Alexa-tyramide 488 (Molecular Probe; diluted 1:100). Hereafter,
sections were incubated with a rabbit anti-c-Fos antiserum (c-Fos
antibody dilution: 1:500; code no: 9412, [23] and visualized by
Alexa568-conjugated goat anti-rabbit antibody (Molecular Probe;
diluted 1:1,000). Counting of GAL- and c-Fos-expressing neurons
in the VLPO and SCN was conducted using a confocal
microscope (Zeiss LSM 510; Brock and Michelsen) equipped with
appropriate filter settings for detecting Alexa488 and Alexa568
was used. The quantification method is detailed in Text S1.
Statistical Analysis
Differences in sleep amounts and quantitative EEG variables
were determined by single- or multiple-way ANOVAs, followed by
post hoc t-tests if 5% significance levels were reached. The
differences in number of c-Fos, Gal; or c-Fos+Gal neurons were
assessed by two-way (light and genotype conditions) ANOVA,
followed by post hoc Fisher PLSD.
Supporting Information
Figure S1 Overview of wakefulness expressed per 5-min
intervals in one Opn4
2/2 (left) and one wild-type (right)
animal. Shown are the various LD regimens used, including two
consecutive days of baseline (top), 1-h dark pulse administered at
ZT3 and 1-h light pulse administered at ZT15 (middle) and a 24-h
d under a 1-h:1-h LD cycle (bottom). A minimum of 10 d was
allowed between each experimental condition. Recordings started
1 d prior to each condition to verify that sleep–wake amounts and
architecture returned to baseline values.
Found at: doi:10.1371/journal.pbio.1000067.s001 (1.08 MB TIF)
Figure S2 Heat map of the light (L) and dark (D) and
time-of-day-dependent changes in time spent awake
under the LD 1:1 schedule (see Figure 2B). Waking values
(waking minutes/5-min intervals; warmer colors correspond to
more waking/5 min) over 3 h were aligned according to the onset
(0 h; grey horizontal bars) of the 1-h dark periods. Only in Opn4
2/2
mice does the capacity of the light and dark pulses to shape the
sleep–wake distribution vary with time of day. This is especially
clear between ZT15 and ZT21 during the subjective dark period
(ZT12–24; grey vertical bars). Note that values depicted between
time 1 and 2 at one ZT corresponds to the values between 21a n d0
of the subsequent ZT interval. Also note that Opn4
+/+ mice learn to
anticipate dark-period onset as the day progresses.
Found at: doi:10.1371/journal.pbio.1000067.s002 (4.02 MB TIF)
Figure S3 Relative frequency distribution of episode
duration of NREM sleep (N), REM sleep (R), and waking
(W) episodes under standard LD 12:12 conditions.
Vertical bars represent the number of episodes (mean6standard
error of the mean [SEM]) expressed per hour of time spent in each
state for nine categories of episode duration. For none of the
behavioral states did genotype affect the distribution.
Found at: doi:10.1371/journal.pbio.1000067.s003 (0.55 MB TIF)
Table S1 Duration and number of sustained waking
bouts during baseline recordings under a LD 12:12
schedule. Sustained waking bouts in Opn4
2/2 are longer than in
wild-type animals (Opn4
+/+) during the 12-h light period (p,0.05;
post hoc t-tests). See Text S1 below for selection criteria of
sustained waking bouts. All values represent means61 SEM (both
days n=9/genotype; for some mice the first or second day could
not be included; Opn4
+/+: day 1 n=7, day 2 n=5;Opn4
2/2 day 1
n=9, day 2 n=6).
Found at: doi:10.1371/journal.pbio.1000067.s004 (0.03 MB
DOC)
Table S2 ECoG theta activity during REMS differed
between genotypes. ECoG power density at peak frequency
was higher both in absolute and relative terms (not shown, but see
Figure 6) in Opn4
2/2 mice. In the light period, theta oscillated at a
higher frequency in Opn4
2/2 mice, reaching values normally
attained during the dark period. As a result, the normal LD
difference in theta peak frequency was absent in Opn4
2/2 mice.
An asterisk (*) indicates significant genotype differences; a section
mark (1) indicates significant LD differences (p,0.03; post hoc t-
test). Values represent mean6SEM (light period: n=8 and 9; dark
period: n=7 and 7, for Opn4
2/2 and Opn4
+/+, respectively).
Found at: doi:10.1371/journal.pbio.1000067.s005 (0.03 MB
DOC)
Text S1 Supplemental experimental procedures: de-
tailed procedures.
Found at: doi:10.1371/journal.pbio.1000067.s006 (0.04 MB
DOC)
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